ダビガトランエテキシラートメタンスルホン酸塩製剤。海外のBoehringer Ingelheim社によるパッケージ。
プラザキサ 75mg
Each Hard Capsule Contains: Dabigatran Etexilate 75mg Equivalent to Dabigatran Etexilate Mesylate 86.48mg as Active Ingredient.
プラザキサ 110mg
Each Hard Capsule Contains 126.83 mg Dabigatran Etexilate Mesylate, Equivalent to 110 mg Dabigatran Etexilate as the Active Ingredient.
プラザキサ 150mg
Each Hard Capsule Contains 150mg Dabigatran Etexilate Equivalent To 172.95 mg Dabigatran Etexilate Mesylate As Active Ingredient.
|